Literature DB >> 11819737

Intensify standardized therapy for esophageal and stomach cancer in tumor hospitals.

S J Wang1, D G Wen, J Zhang, X Man, H Liu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11819737      PMCID: PMC4688705          DOI: 10.3748/wjg.v7.i1.80

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  18 in total

1.  A new method of extensive resection for gastric carcinoma: selective type III operation.

Authors:  Chao-Hong Lin
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

Review 2.  Radical surgery for gastric cancer. A review of the Japanese experience.

Authors:  Y Noguchi; T Imada; A Matsumoto; D G Coit; M F Brennan
Journal:  Cancer       Date:  1989-11-15       Impact factor: 6.860

3.  Endoscopic aspiration mucosectomy as curative endoscopic surgery; analysis of 24 cases of early gastric cancer.

Authors:  A Torii; M Sakai; T Kajiyama; H Kishimoto; G Kin; K Inoue; T Koizumi; S Ueda; M Okuma
Journal:  Gastrointest Endosc       Date:  1995-11       Impact factor: 9.427

4.  Intraoperative radiotherapy: the Japanese experience.

Authors:  M Abe; M Takahashi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-07       Impact factor: 7.038

5.  The role of neoadjuvant therapy in surgically resectable esophageal cancer.

Authors:  S G Swisher; E C Holmes; K K Hunt; J E Doty; M J Zinner; D W McFadden
Journal:  Arch Surg       Date:  1996-08

6.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

Review 7.  Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer.

Authors:  D A Antonioli
Journal:  Hum Pathol       Date:  1994-10       Impact factor: 3.466

8.  Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992.

Authors:  J D Roder; K Böttcher; J R Siewert; R Busch; P Hermanek; H J Meyer
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860

9.  Multimodality therapy for adenocarcinoma of the esophagus.

Authors:  K S Naunheim; P J Petruska; T S Roy; J M Schlueter; H Kim; A E Baue
Journal:  Ann Thorac Surg       Date:  1995-05       Impact factor: 4.330

10.  Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report.

Authors:  A A Forastiere; M B Orringer; C Perez-Tamayo; S G Urba; M Zahurak
Journal:  J Clin Oncol       Date:  1993-06       Impact factor: 44.544

View more
  5 in total

1.  The effects of the formula of amino acids enriched BCAA on nutritional support in traumatic patients.

Authors:  Xin-Ying Wang; Ning Li; Jun Gu; Wei-Qin Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

2.  Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: a case-control study.

Authors:  L Cai; S Z Yu; Z F Zhang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis.

Authors:  Shi-Min Luo; Li-Jian Liang; Jia-Ming Lai
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

4.  Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma.

Authors:  Wei-Hua Fu; Lu-Hua Wang; Zong-Mei Zhou; Jian-Rong Dai; Yi-Min Hu; Lu-Jun Zhao
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

5.  A new three-layer-funnel-shaped esophagogastric anastomosis for surgical treatment of esophageal carcinoma.

Authors:  Han-Lei Dan; Yang Bai; Hui Meng; Cong-Lin Song; Jie Zhang; Yong Zhang; Lei-Chi Wan; Ya-Li Zhang; Zhen-Shu Zhang; Dian-Yuan Zhou
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.